Patientory
A blockchain-based platform for secure health data management, analytics, and incentivized patient engagement.
Website: https://patientory.com/
Cover Block
| Name | Patientory |
| Tagline | A blockchain-based platform for secure health data management, analytics, and incentivized patient engagement. |
| Headquarters | Atlanta, United States |
| Founded | 2015 |
| Stage | Series A |
| Business Model | B2B2C |
| Industry | Healthtech |
| Technology | Blockchain / Web3 |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Undisclosed |
| Total Disclosed Funding | $9.38M (estimated) [Dealroom.co, 2026] |
Links
- Website: https://patientory.com/
- LinkedIn: https://www.linkedin.com/company/patientory
- App Store: https://apps.apple.com/us/app/patientory/id1247860428
- Google Play: https://play.google.com/store/apps/details?id=com.patientory.mobile&hl=en_US&gl=US
Summary and Signal
Patientory is a health data management company using blockchain to create a secure, patient-owned data ecosystem. Founded in 2015 by Chrissa McFarlane, the company has evolved from a token-centric concept into a compliance-first enterprise SaaS model [Hypepotamus, 2026]. Its core offering is a dual-platform approach: a consumer-facing mobile wallet for patients to control and monetize their health data, and the Neith enterprise platform, which provides healthcare organizations with analytics for population health and AI-driven clinical trial recruitment [World Economic Forum, 2022].
McFarlane brings over a decade of healthcare technology experience, having been recognized as a Forbes Top 50 Woman in Tech and serving in leadership roles with HIMSS [Halcyon]. The company's investor list includes strategic names like Novartis and GSK, alongside venture firms such as Gener8tor and R/GA Ventures, with a total of $9.38 million raised across at least 13 discrete funding rounds [Dealroom.co, 2026]. The business model targets recurring enterprise contracts, evidenced by an active pilot in South Korea projected to generate an estimated $150,000 to $250,000 in annual recurring revenue [koreatechdesk.com, 2026].
Data Accuracy: YELLOW -- Core product claims and founder background are well-sourced; funding history is corroborated by Dealroom.co but shows significant variance across other aggregators.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Series A |
| Business Model | B2B2C |
| Industry / Vertical | Healthtech |
| Technology Type | Blockchain / Web3 |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | Undisclosed |
Company Overview
Patientory Inc. was founded in December 2015 by Chrissa McFarlane [Patientory Blog, 2018] [MM+M, 2018]. Headquartered in Atlanta, Georgia, the company was incorporated as a for-profit entity [Crunchbase] [LinkedIn].
Key operational milestones trace a path from concept to a maturing enterprise platform. The company joined the StartUp Health accelerator in 2016 [StartUp Health, May 2021]. A significant technical milestone was the development of its proprietary blockchain network, the PTOYMatrix [PTOY.org] [PranaChain, 2025]. By 2018, founder Chrissa McFarlane served as co-chair of the HIMSS Blockchain Workgroup [HPN Online].
The company's business model has evolved from a token-centric, web3 narrative with its $PTOY cryptocurrency toward a compliance-first, enterprise SaaS model [Hypepotamus, 2026]. This strategic pivot is underscored by its recent global expansion, including a confirmed enterprise pilot in South Korea projected to onboard over 1,000 users in 2026 [koreatechdesk.com, 2026].
Data Accuracy: GREEN -- Company founding and HQ confirmed by Crunchbase and LinkedIn; strategic milestones and model evolution corroborated by multiple independent reports.
The Product and the Stack
Patientory's product architecture is a dual-platform structure, anchored by a proprietary blockchain network. The consumer-facing Patientory mobile app functions as a personal health data wallet [World Economic Forum, 2022]. The app integrates lifestyle tracking features and uses AI to provide health insights and a personalized care plan [Patientory] [StartUp Health, May 2021]. The enterprise counterpart, Neith, is a data management and analytics platform for healthcare organizations. It aggregates siloed clinical, lifestyle, and social determinants of health data to provide population health analytics and support AI-driven clinical trial recruitment [MIT Solve, 2022] [World Economic Forum, 2022].
The underlying technology is the PTOYMatrix, a private, permissioned blockchain network [Patientory Association, 2026] [PTOY.org]. The network uses a native utility token, $PTOY, to facilitate transactions [PTOY.org]. A recent strategic shift has seen Patientory move toward a compliance-first enterprise SaaS model, emphasizing recurring contracts and enhanced API infrastructure [Hypepotamus, 2026]. This evolution is exemplified by the CareGLP affiliate program, a weight management telemedicine service [Patientory, 2026] [Instagram, 2024].
Data Accuracy: GREEN -- Product claims and technical architecture are consistently described across the company website, World Economic Forum, MIT Solve, and recent press coverage [Hypepotamus, 2026].
The Market They Are Entering
The market for secure, interoperable health data platforms is expanding into a core infrastructure layer for value-based care and clinical research.
| Metric | Value |
|---|---|
| Healthcare Data Analytics (2022) | $35.7B |
| Clinical Trial Management Software (2023) | $1.8B |
Demand is driven by the push for value-based care models and the need for life sciences companies to accelerate clinical trial timelines [World Economic Forum, 2022] [MIT Solve, 2022]. On the consumer side, growing awareness of data privacy is creating a receptive audience for tools that offer control of personal health information [Center for a Digital Future, 2023].
Regulatory forces like the 21st Century Cures Act mandate greater data interoperability, which structurally benefits platforms like Patientory [Hypepotamus, 2026]. The company's reported pivot to a compliance-first, enterprise SaaS model addresses the healthcare sector's inherent conservatism regarding new technology [Hypepotamus, 2026].
Data Accuracy: YELLOW -- Market sizing figures are cited from third-party analyst reports, but the application to Patientory's specific blockchain-based wedge is an analyst inference.
The Competitive Field
| Company | Positioning | Stage / Funding | Notable Differentiator |
|---|---|---|---|
| Patientory | Blockchain-based platform for secure health data management, analytics, and incentivized patient engagement. | Series A / $9.38M (estimated) | Dual B2B2C model with a proprietary blockchain network (PTOYMatrix) and a native token ($PTOY). |
| Redox | Cloud-based API network for healthcare data interoperability. | Venture-backed / $169.5M | Pure-play enterprise middleware; connects applications to EHR systems. |
| Health Gorilla | Health information network and API platform for clinical data exchange. | Series B / $50M | Focuses on aggregating clinical data from labs, HIEs, and EHRs for providers and payers. |
Patientory's defensible edge rests on its integrated architecture and early regulatory positioning. Founder Chrissa McFarlane's involvement with healthcare interoperability standards bodies provides regulatory and ecosystem credibility [HPN Online]. The company's most plausible 18-month scenario is the scaling of its Korean enterprise pilot to a multi-million dollar ARR contract [koreatechdesk.com, 2026].
Data Accuracy: YELLOW -- Competitor profiles and funding are drawn from public databases; Patientory's differentiation claims are sourced from its own materials and ecosystem profiles.
Opportunity
If Patientory successfully executes on its pivot to a compliance-first enterprise platform, it could become the default infrastructure for patient-consented health data exchange and analytics.
| Scenario | What happens | Catalyst |
|---|---|---|
| Enterprise SaaS Dominance | Neith becomes the preferred population health analytics platform for self-insured employers and regional payers. | A major reference customer publicly deploys Neith. |
| Clinical Research Infrastructure | The platform becomes a standard tool for patient recruitment and data management in decentralized clinical trials. | A partnership with a top-10 pharmaceutical company or CRO. |
| APAC Expansion Launchpad | South Korea serves as a blueprint for rapid adoption across Asia-Pacific. | The Korean pilot achieves its projected $150K-$250K in ARR. |
Data Accuracy: YELLOW -- Growth scenarios and expansion plans are cited from company blogs and regional tech press; the underlying pilot projections and business model pivot are reported but not independently verified by financial filings.
Sources
- [Dealroom.co, 2026] Patientory funding history | https://tracxn.com/d/companies/patientory/__pko-Au8XhBTUTqOBoXoB1SYhzh0CKqSEtSnzuX9ID8k/funding-and-investors
- [Hypepotamus, 2026] Patientory business model pivot | https://hypepotamus.com/companies/patientory/
- [World Economic Forum, 2022] Patientory organization profile | https://www.weforum.org/organizations/patientory/
- [Halcyon] Chrissa McFarlane profile | https://halcyonhouse.org/fellows/chrissa-mcfarlane/
- [koreatechdesk.com, 2026] Patientory South Korea expansion | https://www.koreatechdesk.com/patientory-south-korea-expansion/
- [Patientory Blog, 2018] Chrissa McFarlane award | https://patientory.com/blog/2018/10/15/patientory-founder-wins-2018-medtech-insight-award
- [MM+M, 2018] Chrissa McFarlane founding story | https://www.mmm-online.com/home/channel/people-on-the-move/patientory-founder-chrissa-mcfarlane-on-her-journey-from-jamaica-to-healthcare-entrepreneur/
- [Crunchbase] Patientory company profile | https://www.crunchbase.com/organization/patientory-2
- [LinkedIn] Patientory, Inc. LinkedIn page | https://www.linkedin.com/company/patientory
- [StartUp Health, May 2021] Patientory video profile | https://www.youtube.com/watch?v=MO8A-A6bxk4
- [PTOY.org] PTOYMatrix description | https://ptoy.org/
- [PranaChain, 2025] Patientory blockchain network | https://pranachain.com/patientory-blockchain-health-data/
- [HPN Online] Chrissa McFarlane HIMSS role | https://www.hpnonline.com/people/patientory-founder-chrissa-mcfarlane-named-co-chair-himss18-blockchain-workgroup
- [MIT Solve, 2022] Patientory solution for equitable health systems | https://solve.mit.edu/challenges/equitable-health-systems/solutions/58486
- [Patientory] Patientory website | https://patientory.com/
- [businessmodelcanvastemplate.com, 2026] Patientory business model | https://businessmodelcanvastemplate.com/patientory-business-model-canvas/
- [Instagram, 2024] CareGLP affiliate program | https://www.instagram.com/p/C6zXqKvOQ-7/
- [Patientory, 2026] CareGLP weight management program | https://patientory.com/careglp
- [Patientory Association, 2026] Neith Enterprise platform | https://patientoryassociation.org/neith-enterprise
- [Grand View Research, 2022] Healthcare data analytics market size | https://www.grandviewresearch.com/industry-analysis/healthcare-data-analytics-market
- [Global Market Insights, 2023] Clinical trial management software market size | https://www.gminsights.com/industry-analysis/clinical-trial-management-software-market
- [Center for a Digital Future, 2023] Patientory data ownership profile | https://www.centerforadigitalfuture.org/blog/60kqfdgb4f8kljqy1j4ujvaqr1bx5y-364pg-bskhw-58gfs-c9t7w-xg5pd
- [Tracxn, 2026] Patientory investors list | https://tracxn.com/d/companies/patientory/__pko-Au8XhBTUTqOBoXoB1SYhzh0CKqSEtSnzuX9ID8k
Articles about Patientory
- Patientory's Korean Pilot Anchors a $9.4 Million Bet on Data Sovereignty — The blockchain health data company, backed by Novartis and GSK, has pivoted to a compliance-first enterprise model with a live pilot projected to bring in $150,000 to $250,000 in annual revenue.